Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2596 to 2610 of 9026 results

  1. Insertion of Stoma Preservation Device

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Coronary venous arterialisation in patients with refractory angina

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Image-guided high intensity focused ultrasound to treat breast cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. MemoKath Stent Insertion

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Non-Invasive Fat Reduction and Body Contouring

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Thromboaspiration for Intermediate risk Pulmonary Embolism

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Implantable Vagus Nerve Stimulator in Heart Failure

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. Cervical ripening ballon for the induction of labour in women who have previously undergone cesarean section

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Pembrolizumab with chemotherapy with or without bevacizumab for treating platinum-resistant recurrent ovarian cancer after 1 or 2 treatments [ID6363]

    In development Reference number: GID-TA11422 Expected publication date:  18 November 2026

    Technology appraisal guidance
    In development

  12. Nipocalimab for treating generalised myasthenia gravis [ID6562]

    Awaiting development Reference number: GID-TA11492 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Cabozantinib with atezolizumab for treating hormone-relapsed metastatic prostate cancer after 1 hormonal treatment [ID6387]

    Awaiting development Reference number: GID-TA11438 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Maralixibat for treating progressive familial intrahepatic cholestasis [ID3818]

    In development Reference number: GID-TA11410 Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation